1
|
Baddour LM, Esquer Garrigos Z, Rizwan Sohail M, Havers-Borgersen E, Krahn AD, Chu VH, Radke CS, Avari-Silva J, El-Chami MF, Miro JM, DeSimone DC. Update on Cardiovascular Implantable Electronic Device Infections and Their Prevention, Diagnosis, and Management: A Scientific Statement From the American Heart Association: Endorsed by the International Society for Cardiovascular Infectious Diseases. Circulation 2024; 149:e201-e216. [PMID: 38047353 DOI: 10.1161/cir.0000000000001187] [Citation(s) in RCA: 30] [Impact Index Per Article: 30.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/05/2023]
Abstract
The American Heart Association sponsored the first iteration of a scientific statement that addressed all aspects of cardiovascular implantable electronic device infection in 2010. Major advances in the prevention, diagnosis, and management of these infections have occurred since then, necessitating a scientific statement update. An 11-member writing group was identified and included recognized experts in cardiology and infectious diseases, with a career focus on cardiovascular infections. The group initially met in October 2022 to develop a scientific statement that was drafted with front-line clinicians in mind and focused on providing updated clinical information to enhance outcomes of patients with cardiovascular implantable electronic device infection. The current scientific statement highlights recent advances in prevention, diagnosis, and management, and how they may be incorporated in the complex care of patients with cardiovascular implantable electronic device infection.
Collapse
|
2
|
Kranick S, Mishra N, Theertham A, Vo H, Hiltner E, Coromilas J, Kassotis J. A Survey of Antibiotic Use During Insertion of Cardiovascular Implantable Devices Among United States Implanters. Angiology 2023; 74:351-356. [PMID: 35816293 DOI: 10.1177/00033197221114689] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
Abstract
Antibiotic use for cardiovascular implantable devices (CIED) prophylaxis is well-accepted despite a paucity of data. Pre-procedural prophylaxis lowers the rate of CIED infections; however, data is lacking for intra- or post-procedural antibiotic use. Antibiotic-eluting envelopes (ENVELOPE) [TYRX®TM] have been shown to reduce post-procedural infections. Understanding implanter practices may provide insight as to the need for antibiotic stewardship. The purpose of this survey was to assess the practices of implanters nationally. A survey was completed by 150 implanters across the US. Participants were board certificated, implanters of CIEDs, with varying experience (1-25 years), in various hospital settings. Of the respondents, 97% reported routine use of systemic antibiotics pre-operatively. About two-thirds of implanters continue systemic antibiotics post-operatively, with half continuing antibiotics for >24 h; 83% of implanters add antibiotic to saline for the purpose of irrigating the wound; 55% routinely use ENVELOPE on approximately 38% of patients. Common reasons cited for ENVELOPE use were infection concerns, significant risk factors, prior device infection, and immunosuppressed status. Two-thirds of respondents use systemic antibiotics during generator changes, with >50% continuing antibiotics for >24 h. This study suggests wide variations in practice among implanters. Additional attention to existing guidelines and evidence regarding appropriate use of ENVELOPE is still needed.
Collapse
Affiliation(s)
- Stephen Kranick
- Department of Medicine, 12287Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ, USA
| | - Nikita Mishra
- Department of Medicine, 12287Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ, USA
| | - Arjun Theertham
- Department of Medicine, Division of Cardiology Rutgers, 12287Robert Wood Johnson Medical School, New Brunswick, NJ, USA
| | - Hung Vo
- Department of Medicine, Division of Cardiology Rutgers, 12287Robert Wood Johnson Medical School, New Brunswick, NJ, USA
| | - Emily Hiltner
- Department of Medicine, Division of Cardiology Rutgers, 12287Robert Wood Johnson Medical School, New Brunswick, NJ, USA
| | - James Coromilas
- Department of Medicine, Division of Cardiology Rutgers, 12287Robert Wood Johnson Medical School, New Brunswick, NJ, USA
| | - John Kassotis
- Department of Medicine, Division of Cardiology Rutgers, 12287Robert Wood Johnson Medical School, New Brunswick, NJ, USA
| |
Collapse
|
3
|
Ziacchi M, Massaro G, Angeletti A, Statuto G, Diemberger I, Martignani C, Galiè N, Biffi M, Boriani G. Preoperative checklist to reduce the risk of cardiac implantable electronic device infections. PACING AND CLINICAL ELECTROPHYSIOLOGY: PACE 2021; 45:262-269. [PMID: 34927271 DOI: 10.1111/pace.14429] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/14/2021] [Revised: 12/03/2021] [Accepted: 12/10/2021] [Indexed: 10/19/2022]
Abstract
Cardiac implantable electronic device (CIED) infection represents a dramatic event with a high mortality rate (>3x) despite antibiotic therapy and device extraction; therefore, the real winning strategy in this situation could be represented by prevention. Antibiotic prophylaxis and antibiotic-releasing envelope are effective in improving patient outcome; however, healthcare costs related to CIED infections remain high over the years. In this review we would keep the attention on a pre-surgical checklist to reduce the risk of CIED infections. In fact, checklist is an effective instrument for medical care quality improvement mainly used in surgery, but not very commonly in cath-lab and electrophysiology procedures. All steps of this checklist are of proven effectiveness in reducing the risk of CIED infections but, up till now, they are not considered together in a pre-surgical approach. This article is protected by copyright. All rights reserved.
Collapse
Affiliation(s)
- Matteo Ziacchi
- Cardiology Unit, Cardio-Thoracic-Vascular Building, S.Orsola-Malpighi Policlinic, University of Bologna, Bologna, Italy
| | - Giulia Massaro
- Cardiology Unit, Cardio-Thoracic-Vascular Building, S.Orsola-Malpighi Policlinic, University of Bologna, Bologna, Italy
| | - Andrea Angeletti
- Cardiology Unit, Cardio-Thoracic-Vascular Building, S.Orsola-Malpighi Policlinic, University of Bologna, Bologna, Italy
| | - Giovanni Statuto
- Cardiology Unit, Cardio-Thoracic-Vascular Building, S.Orsola-Malpighi Policlinic, University of Bologna, Bologna, Italy
| | - Igor Diemberger
- Cardiology Unit, Cardio-Thoracic-Vascular Building, S.Orsola-Malpighi Policlinic, University of Bologna, Bologna, Italy
| | - Cristian Martignani
- Cardiology Unit, Cardio-Thoracic-Vascular Building, S.Orsola-Malpighi Policlinic, University of Bologna, Bologna, Italy
| | - Nazzareno Galiè
- Cardiology Unit, Cardio-Thoracic-Vascular Building, S.Orsola-Malpighi Policlinic, University of Bologna, Bologna, Italy
| | - Mauro Biffi
- Cardiology Unit, Cardio-Thoracic-Vascular Building, S.Orsola-Malpighi Policlinic, University of Bologna, Bologna, Italy
| | - Giuseppe Boriani
- Cardiology Unit, University of Modena and Reggio Emilia, Modena, Italy
| |
Collapse
|
4
|
A review of cardiovascular involvements associated with medications used to treat COVID-19 infection. COR ET VASA 2021. [DOI: 10.33678/cor.2020.073] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
5
|
Liu J, Yu M, Zeng G, Cao J, Wang Y, Ding T, Yang X, Sun K, Parvizi J, Tian S. Dual antibacterial behavior of a curcumin–upconversion photodynamic nanosystem for efficient eradication of drug-resistant bacteria in a deep joint infection. J Mater Chem B 2018; 6:7854-7861. [PMID: 32255030 DOI: 10.1039/c8tb02493f] [Citation(s) in RCA: 31] [Impact Index Per Article: 4.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
The curcumin–upconversion photodynamic nanosystem exhibits dual antibacterial behavior for MRSA-induced periprosthetic joint infection under NIR irradiation.
Collapse
Affiliation(s)
| | - Meng Yu
- Department of Operating Room
- The Affiliated Hospital of Qingdao University
- Qingdao 266071
- China
| | - Guobo Zeng
- Department of Orthopaedics
- The People's Hospital of Xixiu District
- Anshun
- China
| | - Jie Cao
- Department of Pharmaceutics
- School of Pharmacy
- Qingdao University
- Qingdao
- China
| | - Yuanhe Wang
- Department of Orthopaedics
- The Affiliated Hospital of Qingdao University
- Qingdao 266071
- China
| | - Tao Ding
- Medical College
- Qingdao University
- Qingdao
- China
| | - Xu Yang
- Department of Orthopaedics
- The Affiliated Hospital of Qingdao University
- Qingdao 266071
- China
| | - Kang Sun
- Department of Orthopaedics
- The Affiliated Hospital of Qingdao University
- Qingdao 266071
- China
| | - Javad Parvizi
- Department of Orthopaedics
- Rothman Institute at Thomas Jefferson University
- Philadelphia
- USA
| | - Shaoqi Tian
- Department of Orthopaedics
- The Affiliated Hospital of Qingdao University
- Qingdao 266071
- China
| |
Collapse
|